KI-Tool für unternehmerische ethische Dilemmata

Heim

KI-Prompt-Liste

Philosophie/Religion

Ethische Entscheidungsunterstützung

${:__('collect %s',Ethische Entscheidungsunterstützung)}$

Philosophie/Religion

Nutzen Sie KI, um bei der Lösung ethischer Geschäftsprobleme zu helfen und das Gleichgewicht zwischen Stakeholder-Interessen und moralischen Prinzipien zu wahren.

Prompt-Inhalt

Kopieren

Act as a corporate ethics consultant to provide decision-making advice for the following specific business scenario: A pharmaceutical company discovers that its marketed drug has mild but predictable side effects with long-term use, yet stopping the medication carries higher risks. Please analyze how to weigh options such as informing patients, modifying labels, continuing sales, or recalling the product, integrating utilitarian and deontological perspectives to offer comprehensive advice that balances compliance, reputation, and patient safety, while explaining the reasoning.

Kopieren

Treten Sie als Unternehmensethikberater auf, um Entscheidungsberatung für das folgende spezifische Geschäftsszenario zu geben: Ein Pharmaunternehmen stellt fest, dass sein vermarktetes Medikament bei Langzeitanwendung leichte, aber vorhersehbare Nebenwirkungen hat, das Absetzen der Medikation jedoch höhere Risiken birgt. Bitte analysieren Sie, wie Optionen wie die Information der Patienten, die Änderung der Etiketten, die Fortsetzung des Verkaufs oder die Rückrufaktion abgewogen werden können, und integrieren Sie utilitaristische und deontologische Perspektiven, um umfassende Ratschläge zu bieten, die Compliance, Ruf und Patientensicherheit in Einklang bringen, und erläutern Sie die Begründung.

Kopieren

Teilen Klicken Sie, um den Link zu kopieren

Kommentare (0)

0/300

Einreichen

Empfehlung

Ethische Entscheidungsunterstützung

Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its marketed drug has mild but predictable side effects with long-term use, yet the recall cost is extremely high and could lead to bankruptcy, resulting in the job loss of thousands of employees. Please evaluate whether the company should proactively disclose and recall the drug by combining utilitarian considerations of maximizing happiness for the greatest number with deontological principles of honesty and duty, and provide comprehensive advice balancing shareholder interests, patient safety, and social responsibility.

Ethischer Entscheidungsassistent

When a company faces a moral dilemma involving conflicting stakeholders, please analyze the potential impact of different action paths on employees, customers, and the community by combining utilitarian consequence assessment with deontological principle review, and recommend a solution that is ethically most defensible and aligns with the company's long-term values, while explaining how this solution balances short-term interests with long-term reputation risks.

Ethische Entscheidungsunterstützung

Act as a corporate ethics consultant to provide decision-making advice for the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but under-disclosed side effects with long-term use. Recalling it would cause massive financial losses and affect shareholder interests, while not recalling it might harm some patients' health. Please analyze the ethical weights of both paths by combining the impact on overall well-being from a utilitarian perspective with the responsibility for honesty and patient safety from a deontological perspective, and propose a balanced execution plan that considers legal compliance, corporate reputation, and social responsibility, focusing on how to build trust through transparent communication rather than merely avoiding risk.

Ethische Entscheidungsunterstützung

Act as a senior corporate ethics consultant to provide decision-making advice for the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but insufficiently disclosed side effects with long-term use. Recalling it would cause massive financial losses and affect shareholder interests, while not recalling it might harm some patients' health. Please analyze the moral tension in this context by combining the impact on overall well-being from a utilitarian perspective with the responsibility for honesty and patient safety from a deontological perspective, and propose a balanced execution plan that considers legal compliance, corporate reputation, and social responsibility, focusing on how to establish a sustainable decision-making mechanism between short-term financial pressure and long-term moral credibility.

Ethische Entscheidungsunterstützung

Act as a senior corporate ethics consultant to provide decision-making advice for the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but non-fatal side effects with long-term use, and the cost of recall would bankrupt the company and cause thousands of layoffs, but not recalling it might harm some patients' health. Please analyze whether to proactively disclose and recall the drug by combining utilitarian consequence assessment with deontological respect for the dignity of life, and propose a balanced plan that considers both shareholder interests and public health, focusing on the ethical logic behind the decision rather than mere legal compliance.

Ethische Entscheidungsunterstützung

Act as a corporate ethics consultant to provide decision-making advice for the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has mild but non-fatal side effects with long-term use, yet a recall would bankrupt the company and affect the livelihoods of thousands of employees. Please analyze the moral weight of both recall and non-recall paths by combining utilitarian calculations for the greatest good with deontological respect for patient知情权 and human dignity, and propose a specific execution strategy that balances social responsibility with corporate survival, focusing on how to establish equilibrium between transparency and business sustainability.